It has been documented, to date, in more than 120 males (see Human Tafazzin (TAZ) Gene Mutation & Variation Database). It is believed to be severely under-diagnosed and may be estimated to occur in 1 out of approximately 300,000<unk> s. Family members of the<unk>  Foundation and its affiliates live in the US, Canada, the UK, Europe, Japan, South Africa, Kuwait, and Australia.<unk>  has been predominately diagnosed in males, although by 2012 a female case had been reported. Early diagnosis of the<unk>  is complicated and critical. According to some international literature, it is believed that its prevalence is estimated at around 1 / 454,000 and an incidence at 1 / 140,000 (South West England, South Wales) to 1 / 300,000 - 1 / 400,000 live<unk> s (USA). In other materials, it addresses that the<unk>  affects approximately one in every 200,000<unk> s. In existing cases, the occurrence may be underdiagnosed due to its complex nature. Bringing to the Brazilian reality, there may be cases, however, in scientific literature there are few materials found. The<unk>  is named after neurologist Dr. Peter<unk> , a pediatric neurologist, who through his studies around 1983, described a class scheme demonstrating that the disease is not communicable. There is still no cure for<unk> , but there are ways to stabilize some symptoms of the disease.
Barth syndrome
Worth syndrome
Terson syndrome
Hunan hand syndrome
Limb girdle syndrome
Lamb-Shaffer syndrome
Achard syndrome
Alien hand syndrome